Prostate cancer is one of the most common cancers affecting men around the world. It develops in the prostate, a small gland ...

A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced prostate cancer, according to a phase II clinical trial conducted at Kurume ...

Former President Joe Biden has been diagnosed with metastatic prostate cancer at age 82. The former president's office said he has an "aggressive form" of the cancer, which has spread to his bones.

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

Prostate cancer can be difficult to detect in its beginning stages — here's what to look out for Getty Prostate cancer is one of the most common types of cancer in males. It starts in the prostate, a ...

Researchers have identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an ...

Former President Biden recently revealed he has an aggressive form of prostate cancer that has spread to his bones. The news may have provoked concern in men with an enlarged prostate. But Dr. Pat ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

For Black men with prostate cancer, racial representation is a key factor affecting trust in websites offering information on prostate cancer, reports a study in the March issue of The Journal of ...

Former President Joe Biden is battling “aggressive” prostate cancer after doctors found a “small nodule” on his prostate during a routine medical exam. Prostate cancer is one of the most common ...

Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...